Literature DB >> 17137451

Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality.

Karen Canfell1, Freddy Sitas, Valerie Beral.   

Abstract

OBJECTIVE: To compare cervical screening policy, screening uptake, and changes in cervical cancer incidence and mortality between Australia and the United Kingdom.
DESIGN: Analysis of screening registry data and national cancer statistics.
SETTING: In Australia, organised cervical screening was initiated in 1991 for sexually active women aged 18-69 years, with a recommended 2-yearly interval. In the UK, organised screening began in 1988 for women aged 20-64 years, with a recommended 3-yearly interval in most regions.
RESULTS: Estimated lifetime screening participation rates in 2001 were similar in the two countries, at 88% in Australia and 90% in the UK. For women who were screened and had a negative result, the median time to the next screen was 27 months in Australia and 38 months in the UK. At 39 months, equivalent proportions (74%) had been re-screened in the two countries, and by 60 months the re-screened proportions were 81% in Australia and 94% in the UK. From 1991-1993 to 1998-2000, the incidence of cervical cancer in women aged 20-69 years fell by 33% in Australia and 33% in the UK, and mortality from cervical cancer fell by 36% in both countries.
CONCLUSIONS: After the introduction of organised screening, similar reductions in cervical cancer incidence and mortality were achieved in Australia and the UK. Therefore, the 2-yearly screening policy in Australia and the predominantly 3-yearly screening policy in the UK appear to have been of broadly similar effectiveness.

Entities:  

Mesh:

Year:  2006        PMID: 17137451     DOI: 10.5694/j.1326-5377.2006.tb00661.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  23 in total

1.  From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination.

Authors:  Mahboobeh Safaeian; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2013-10-04       Impact factor: 13.506

2.  Should male circumcision be advocated for genital cancer prevention?

Authors:  Brian J Morris; Adrian Mindel; Aaron Ar Tobian; Catherine A Hankins; Ronald H Gray; Robert C Bailey; Xavier Bosch; Alex D Wodak
Journal:  Asian Pac J Cancer Prev       Date:  2012

3.  Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years.

Authors:  Prudence Creighton; Jie-Bin Lew; Mark Clements; Megan Smith; Kirsten Howard; Suzanne Dyer; Sarah Lord; Karen Canfell
Journal:  BMC Public Health       Date:  2010-11-26       Impact factor: 3.295

4.  Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS).

Authors:  Wendy Nelson; Richard P Moser; Allison Gaffey; William Waldron
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

5.  Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.

Authors:  A Waldmann; S Nolte; M A Weinstock; E W Breitbart; N Eisemann; A C Geller; R Greinert; B Volkmer; A Katalinic
Journal:  Br J Cancer       Date:  2012-01-31       Impact factor: 7.640

6.  Market survey predictions on the future of US Pap testing.

Authors:  R Marshall Austin; Barbara Benstein; Joel Bentz; Sandra Bigner; Gregory G Freund; Gregory La Rocco; Ibrahim Ramzy; Lynnette Savaloja; Vinod B Shidham
Journal:  Cytojournal       Date:  2009-09-18       Impact factor: 2.091

Review 7.  A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities.

Authors:  Michelle B Shin; Gui Liu; Nelly Mugo; Patricia J Garcia; Darcy W Rao; Cara J Bayer; Linda O Eckert; Leeya F Pinder; Judith N Wasserheit; Ruanne V Barnabas
Journal:  Front Public Health       Date:  2021-07-01

8.  Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study.

Authors:  Rosa Legood; Megan Smith; Jie-Bin Lew; Robert Walker; Sue Moss; Henry Kitchener; Julietta Patnick; Karen Canfell
Journal:  BMJ       Date:  2012-10-31

9.  Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia.

Authors:  Nayyereh Aminisani; Bruce K Armstrong; Sam Egger; Karen Canfell
Journal:  BMC Cancer       Date:  2012-10-23       Impact factor: 4.430

10.  Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors.

Authors:  Laura G Currin; Ruth H Jack; Karen M Linklater; Vivian Mak; Henrik Møller; Elizabeth A Davies
Journal:  BMC Public Health       Date:  2009-02-20       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.